News Focus
News Focus
icon url

semi_infinite

03/28/19 11:47 AM

#224342 RE: semi_infinite #224039

EYPT - down 17% on $20M equity financing at 1.90. The good visibility on Yutiq uptake must be slow looking. Dexycu for cataract surgery is a bigger market.

http://www.biotuesdays.com/briefs/2019/3/28/eyepoint-pharma-prices-20-million-stock-offering